|
gptkb:ODYSSEY_Outcomes_Trial
|
changes in non-HDL cholesterol levels
|
|
gptkb:ODYSSEY_Outcomes_Trial
|
quality of life assessments
|
|
gptkb:ODYSSEY_Outcomes_Trial
|
changes in LDL cholesterol levels
|
|
gptkb:CENTAUR_trial
|
hospitalization duration
|
|
gptkb:ODYSSEY_Outcomes_Trial
|
changes in triglyceride levels
|
|
gptkb:VEGF_Trap-Eye_Study
|
reduction in retinal thickness
|
|
gptkb:DAPA-HF_study
|
all-cause mortality
|
|
gptkb:MARINA_trial
|
quality of life
|
|
gptkb:FOURIER_Trial
|
hospitalization for unstable angina
|
|
gptkb:ODYSSEY_Outcomes_Trial
|
changes in apolipoprotein B levels
|